SequelSEC

COMPASS Pathways plc CMPS

Pharmaceutical Preparations · CIK 0001816590 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$179.04M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

COMPASS Pathways plc (CMPS) reported net income of -$287.86M for the fiscal year ended 2025-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from COMPASS Pathways plc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

COMPASS Pathways plc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$179.04M-$178.20M-$136.92M-$110.40M-$83.22M-$51.39M-$21.18M
Net income-$287.86M-$155.12M-$118.46M-$91.50M-$71.74M-$60.33M-$19.61M
Research & development$118.44M$119.04M$87.52M$65.05M$44.03M$23.37M$12.56M
Weighted-average diluted sharesshares 93.50Mshares 67.48Mshares 51.03Mshares 42.44Mshares 40.00Mshares 16.99Mshares 7.48M
Pretax income-$290.34M-$153.53M-$117.68M-$91.10M-$71.54M-$60.30M-$19.60M
Income tax expense-$2.47M$1.59M$780.00K$408.00K$199.00K$32.00K$15.00K
Diluted EPS$-3.08$-2.30$-2.32$-2.16$-1.79$-3.55$-2.62
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$60.60M$59.17M$49.40M$45.35M$39.19M$28.03M$8.62M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

COMPASS Pathways plc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Cash & equivalents$149.61M$165.08M$220.20M$143.21M$273.24M$190.33M$24.97M
Total assets$210.35M$213.67M$275.99M$197.29M$300.90M$203.46MUnavailable
Current assets$191.49M$201.29M$261.30M$191.65M$295.30M$202.40MUnavailable
Total liabilities$263.20M$58.97M$50.24M$16.01M$16.49M$6.90MUnavailable
Current liabilities$247.80M$34.02M$19.60M$15.60M$15.11M$6.90MUnavailable
Total equity incl. NCI-$52.85M$154.70M$225.74M$181.28M$284.41M$196.56M-$30.39M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt$14.11M$24.65M$28.76M$0UnavailableUnavailableUnavailable
Accounts payable$15.22M$12.28M$5.89M$4.76M$2.56M$2.75MUnavailable

Cash flow

COMPASS Pathways plc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Operating cash flow-$157.24M-$119.19M-$97.38M-$105.45M-$67.74M-$41.38M-$17.81M
Capital expendituresUnavailable$0$66.00K$596.00K$334.00K$131.00K$165.00K
Investing cash flowUnavailable$0-$64.00K-$596.00K-$334.00K-$628.00K-$165.00K
Financing cash flow$140.71M$63.82M$173.83M$1.04M$156.65M$194.16M$18.38M
Net change in cash-$15.48M-$55.17M$77.26M-$129.97M$82.99M$165.37M$2.08M
Stock-based compensation$13.59M$19.52M$17.28M$13.12M$8.64M$17.98M$3.25M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailable$242.00K$330.00K$175.00K$112.00K$63.00K

Derived

COMPASS Pathways plc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Free cash flowUnavailableUnavailable-$97.44M-$106.05M-$68.08M-$41.51M-$17.98M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio0.77x5.92x13.33x12.29x19.55x29.36xUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CMPS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-24View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.